About this episode
Sylvia Jablonski, Chief Investment Officer, Co-Founder at Defiance ETFs, discusses investing and gives her 2022 market outlook. Dr. Purvi Parikh, immunologist with the Allergy and Asthma Network, discusses the latest Omicron developments and vaccine effectiveness against the variant. Tim Fiore, Chair for the Institute for Supply Management’s (ISM) Manufacturing Business Survey Committee, discusses the ISM Semiannual Economic Forecast. Michael Cuggino, President and Portfolio Manager of the Permanent Portfolio Family of Funds, discusses investing strategies amid inflation. Hosted by Paul Sweeney and Matt Miller.
See omnystudio.com/listener for privacy information.
Get every episode summarized
Each time Bloomberg Intelligence publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.
Email me new episodesFree for 3 shows. No card needed.
No transcript yet
This episode has not been transcribed. Request it and it moves to the front of the queue.
More episodes
More from Bloomberg Intelligence
GE to Buy Consolidated Precision Products for $11.75 Billion
Bloomberg Intelligence
Introducing: Bloomberg Money
Bloomberg Intelligence
Bloomberg Money: Premium Travel, Fast Fashion, Luxury at the US Open & The Cost...
Bloomberg Intelligence
Anthropic Finalizing $15 Billion Pre-IPO Credit Facility
Bloomberg Intelligence